The region offers strong demand, but regulatory fragmentation and internal complexity could constrain expansion. Southeast Asia’s medtech supply chains need to be deliberately redesigned to support the region’s growth potential, according to KPMG. In its report, KPMG said the region, with a population of more than 700 million, has become a critical growth market for global medtech companies. Supportive government healthcare policies are helping expand healthcare infrastructure and increase proce